Mycotoxins: Gate-openers for Infectious Diseases01 March 2015
Mycotoxins may alter a pig's susceptibility to infectious diseases such as PED, PRRS and PCV by affecting the intestinal health and the innate and adaptive immune system, according to Radka Borutova, DVM PhD, Business Development Manager for NutriAd International NV, Belgium.
Mycotoxins are structurally diverse secondary metabolites of fungi that grow on feedstuffs consumed by animals. Consumption of some mycotoxins, at levels that do not cause overt clinical mycotoxicosis, suppresses immune functions and may decrease resistance to infectious disease.
The sensitivity of the immune system to mycotoxin-induced immunosuppression arises from the vulnerability of the continually proliferating and differentiating cells that participate in immune-mediated activities and regulate the complex communication network between cellular and humoral components. Mycotoxin-induced immunosuppression may be expressed as depressed T or B lymphocyte activity, suppressed immunoglobulin and antibody production, reduced complement or interferon activity, and impaired macrophage-effector cell function.
Although the mode of action of many specific immunosuppressive effects of mycotoxins are presently unclear, inhibition of DNA, RNA and protein synthesis via a variety of different mechanisms appears to be directly or indirectly responsible for the immunosuppressive action of many mycotoxins.
Gastrointestinal tract immunity is severely affected by deoxynivalenol
Deoxynivalenol (DON) is a mycotoxin produced by Fusarium spp. and belongs to trichothecene mycotoxins. Among monogastric farm animals, swine are the most susceptible to DON as it markedly reduces feed intake and decreases weight gain. DON has also been shown to increase susceptibility to viral infections (Savard et al., 2014). The economic costs of mycotoxins are impossible to determine accurately (Wu et al., 2008) but the US Food and Drug Administration (FDA) estimated that in the US the mean economic annual cost of crop losses from the mycotoxins aflatoxins, fumonisins, and deoxynivalenol are US$932 million (CAST report, 2003).
The intestinal mucosa acts as a barrier, preventing the entry of foreign antigens including food proteins, drugs, toxins, commensal microbiota and pathogens into the underlying tissues (Bouhet and Oswald, 2005). Following oral intake of low to moderate amounts of deoxynivalenol, the gastro-intestinal epithelial cell layer will be exposed first. The mucosal immunity, which consists of an innate and adaptive immune system, can be affected by DON (Oswald, 2006). Important components of the innate immune system are the intestinal epithelial cells, which are interconnected by tight junctions, and covered with mucus, produced by goblet cells (Schenk and Mueller, 2006).
Several studies indicate that DON is able to increase the permeability of the porcine intestinal epithelial layer (Pinton et al., 2009) and affect viability and proliferation of porcine intestinal epithelial cells (Yunus et al., 2012) Several mycotoxins are also able to modulate the production of cytokines while DON increases the expression of TGF-β and IFN-γ in intestinal epithelial cells (Bouhet and Oswald, 2005).
At the cellular level, the main toxic effect of DON appears to be a primary inhibition of protein synthesis followed by disruption of DNA and RNA synthesis. DON affects actively dividing cells such as those lining the gastrointestinal tract. It should be noted that the gastrointestinal tract is also sensitive to DON induced apoptosis, since such changes in the gastric mucosa, gastric granular epithelium and intestinal crypt cell epithelium (Bondy and Pestka, 2000).
Viruses are more effective in presence of mycotoxins
Fusarium mycotoxins including DON negatively affect the intestinal reovirus clearance. Li et al. (2006) showed that DON and T-2 suppress the host immune response to reovirus as evidenced by the inability to clear the virus from the intestine as well as by increased faecal shedding of the virus. Trichothecene exposure increased the intestinal viral load, which could increase inflammation and discomfort to the host during the infection process. The increased faecal shedding could enhance virus dissemination among individuals (Li et al. 2006). These results could assume an impact of mycotoxins on host susceptibility to more virulent and aggressive viruses as PRRS, PCV2 or PED.
PRRSV is a highly infectious virus that replicates within the monocytes or macrophages with the lung being a predominant site of viral multiplication (Ramos et al., 2010). Exposure of piglets to another Fusarium mycotoxin - fumonisin B1 (FB1) increased the risk for PRRSV disease (Bane et al., 1992). More severe histopathological lesions were observed when pigs were exposed to FB1 and subsequently inoculated with PRRSV. The authors suggest that FB1 causes immunosuppression, facilitating PRRSV to induce more severe lesions (Ramos et al., 2010).
The porcine epidemic diarrhoea (PED) virus pathogenesis and immune mechanisms are similar to those reported for TGE (Transmissible Gastro Enteritis). Oral infection results in viral replication in the epithelial cells of the small intestinal villi. Cells on colonic villi also become infected. On large breeding farms, the virus persists in consecutive litters of pigs after weaning and after they lose their immunity from antibody in the milk. On these farms, the virus may be associated with weaning diarrhoea.
The integrity of the gut is dependent on the maintenance of various factors, including enterocyte and mucus layer integrity, as well as preservation and functionality of epithelial junctions cells (Randal et al., 2011). There is increasing evidence that the intestinal epithelium is repeatedly exposed to mycotoxins, and at a higher concentration than other tissues (Grenier and Applegate, 2013). The ingestion of mycotoxins may induce changes on intestinal morphology and local immunity (Bracarense et al., 2012) affecting the barrier function of the gut and finally open door for viral infections as PED or TGE. Given the importance of PED in worldwide swine production and the frequent occurrence of different mycotoxins including DON, more detailed research should be performed investigating their interaction.
An important role of mycotoxins should be highlighted in aetiology of such important disease as porcine ear necrosis syndrome (PENS). PENS is usually the result of a mixed infections causing damage to the skin. Staphylococcus hyicus is the most common isolated agent in lesions of PENS cases, but other pathogens such as Mycoplasma suis, Streptococcus suis and spirochaetes are often implicated (Thacker, 2006).
Moreover, non-infectious factors such as intensive pen density and overpopulation, poor air quality with high concentrations of gases (e.g. ammonia), poor hygienic conditions, copper and magnesium deficiency and cannibalism, were associated with an increased risk of incidence of PENS (Busch et al., 2008).
Recently, an important causative role has also been attributed to immunosuppressive agents such as Porcine Circovirus type 2 (PCV2), Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), as well as mycotoxins (Allan and Ellis, 2000).
Diagnosis of mycotoxin problem
There is a need for reliable and readily available laboratory diagnosis of mycotoxins in feedstuffs. Many mycotoxins are present in so-called "masked" or "conjugated" form and those cannot be analysed by routine analytical methods. Synergistic and additive interactions between more mycotoxins or mycotoxins and infectious agents should be taken into consideration.
Veterinarians, feed company representatives and other people involved should ensure that feed samples are taken properly, identified unmistaken and submitted to reliable analytical laboratories.
Feed companies would be well advised to perform tests of either unprocessed grain or of the final (pelleted or crumbled) product on a regular basis to ensure wholesomeness of their product. Attention to the possibility of occurrence of mycotoxins should be of particular concern. Rapid test kits based on ELISA method are already used worldwide.
There are no "safe" or "unsafe" levels of mycotoxins. Low to medium levels might be much more dangerous because they are underestimated and cause subclinical effects as immune-suppression or suppression of antioxidant system functions.
Any disease outbreak deserves to be thoroughly investigated from various angles, e.g. necropsies of dead animals; attempts to isolate viruses and thorough investigations at the time when problems occur should be done.
In conclusion, mycotoxins may alter the animal susceptibility to infectious diseases by affecting the intestinal health and the innate and adaptive immune system.
Further research will be necessary to investigate the impact of mycotoxins on infectious diseases and to develop practical, economically justified, solutions to counteract mycotoxin contamination of feed, and its effects on animal health.
- Allan G.M. and Ellis J.A. 2000. Porcine circovirus: a review. J. Vet. Diagn. Invest. 12(1):3-14.
- Bane D.P., Neumann E.J., Hall W.F., Harlin K.S., Slife, R.L.N. 1992. Relationship between fumonisin contamination of feed and mystery swine disease-a case-control study. Mycopathologia. 117:121-124.
- Bondy, G.S., and Pestka J.J. 2003. Immunomodulation by fungal toxins. J. Toxicol. Environ. Health Part B. Crit. Rev. 109-143.
- Bracarense A.P., Lucioli J., Grenier B., Pacheco G.D., Moll W.D., Schatzmayr G., Oswald I.P. 2012. Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. Br. J. Nutr. 107:1776-1786.
- Busch M.E., Wachmann H., Nielsen E.O. 2008. Risk factors for each necrosis and tail lesions in weaners. In Proceedings of 20th International Pig Veterinary Society Congress, Durban, South Africa. OR.12.12.
- CAST Report. Mycotoxins: risks in plant, animal, and human systems. In: J.L. Pinton P., Nougayrède J.P., Del Rio J.C., Moreno C., Marin D.E., Ferrier L., Bracarense A.P., Kolf-Clauw M., Oswald I.P. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol, Appl, Pharm, 2009; 237, 41-48. Richard, G.A. Payne (Eds.), Council for Agricultural Science and Technology Task Force Report 2003; No. 139, Ames, Iowa, USA. ISBN 1-887383-22-0.
- Bouhet S., Oswald I.P. 2005. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Vet. Immunol. Immun. 108:199-209.
- Grenier B., Applegate T.J. 2013. Modulation of intestinal functions following mycotoxin ingestion: Meta-analysis of published experiments in animals. Toxins. 5:396–430.
- Li M., Cuff C.F., Pestka J.J. 2006. T-2 toxin impairment of enteric reovirus clearance in the mouse associated with suppressed immunoglobulin and IFN-γ responses. Toxicol. Appl. Pharm. 214:318-325.
- Oswald, I.P. 2006. Role of intestinal epithelial cells in the innate immune defense of the pig intestine. Vet. Res. 37:359-368.
- Ramos C.M., Martinez E.M., Carrasco A.C., Puente J.H.L., Quezada F., Perez J.T., Oswald I.P., Elvira S.M. 2010. Experimental trial of the effect of fumonisin B and the PRRS virus in swine. J. Anim. Vet. Adv. 9:1301-1310.
- Randall K., Turton J., Foster J.R. 2011. Explant culture of gastrointestinal tissue: A review of methods and applications. Cell Biol. Toxicol. 27:267-284.
- Savard C., Pinilla V., Provost C., Segura M., Gagnon C.A., Chorfi Y. 2014. In vitro effect of deoxynivalenol (DON) mycotoxin on porcine reproductive and respiratory syndrome virus replication. Food Chem. Toxicol. 65:219-226.
- Schenk, M., Mueller, C. 2008. The mucosal immune system at the gastrointestinal barrier. Best Pract. Res. CL GA. 22:391-409.
- Thacker E.L. 2006. Mycoplasmal Diseases. In: Straw B.E., Zimmerman J.J., D'Allaire S.D. et al., Eds. Diseases of Swine, 9th ed. Iowa, Ames: Iowa State Press. 701-717.
- Yunus A.W., Blajet-Kosicka A., Kosicki R., Khan M.Z., Rehman H., Bohm, J. 2012. Deoxynivalenol as a contaminant of broiler feed: Intestinal development, absorptive functionality and metabolism of the mycotoxin. Poult. Sci. 91:852-861.
- Wu T.S., Liao Y.C., Yub F.Y., Chang C.H., Liu B.H. 2008. Mechanism of patulin-induced apoptosis in human leukemia cells (HL-60). Toxicol. Lett. 183:105-111.